Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Erdinc Sezgin, who will be part of the prestigious SciLifeLab Fellowship programme and the Karolinska Institutet.

Formerly a member of the Eggeling lab at MRC HIU, Erdinc will lead the Cell Signalling, Immunity and Nanoimaging Lab (CSI:Nano), working on biophysical and physicochemical aspects of cell signalling using advanced technologies in imaging and synthetic biology.

The SciLifeLab Fellows program is a career program aimed at strengthening Swedish research in Molecular Biosciences and supporting a long-term societal impact. The Sezgin group is specifically hosted by the Karolinska Institutet. The host universities provide an advantageous economic starting package and together with SciLifeLab, a strong interdisciplinary research environment in close proximity to a cutting-edge research infrastructure.

SciLifeLab, Science for Life Laboratory, was founded in 2010 as a joint effort between four universities: Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University and Uppsala University. Today, they support research activities at all major Swedish universities.

We wish all the best to Erdinc in his future endeavours. More information about the Sezgin group can be found here.

Similar stories

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy

The paper, published in Nature Communications reveals key genes involved in the common developmental disease.